|
OMIM |
Link |
Information gain |
01 |
|
saccharopinuria
|
[NCBI]
|
0.00202368
|
|
|
folic acid, transport defect involving
|
[NCBI]
|
0.00183065
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
0.00169396
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
0.00135171
|
|
|
CGD
|
[NCBI]
|
0.00134834
|
|
|
phenylketonuria ii
|
[NCBI]
|
0.000434624
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
0.000349604
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
0.000232667
|
|
|
GMPR
|
[NCBI]
|
0.000226761
|
|
|
NDUFA13
|
[NCBI]
|
0.000207596
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
0.000180929
|
|
|
RA
|
[NCBI]
|
0.000178238
|
|
|
ophthalmoplegic neuromuscular disorder with abnormal mitochondria
|
[NCBI]
|
0.000159608
|
|
|
MTND1
|
[NCBI]
|
0.000159042
|
|
|
CYBA
|
[NCBI]
|
0.000141909
|
|
|
leber optic atrophy
|
[NCBI]
|
0.000141148
|
|
|
NCF1
|
[NCBI]
|
0.000136098
|
|
|
NDUFS4
|
[NCBI]
|
0.000121256
|
|
|
SLE
|
[NCBI]
|
0.000116236
|
|
|
GMPR2
|
[NCBI]
|
0.000115718
|
|
|
NCF2
|
[NCBI]
|
0.000111411
|
|
|
LS
|
[NCBI]
|
0.000105367
|
|
|
NDUFS2
|
[NCBI]
|
0.000103677
|
|
|
mitochondrial complex iii deficiency
|
[NCBI]
|
9.81062e-05
|
|
|
NDUFV2
|
[NCBI]
|
9.77062e-05
|
|
|
NDUFV1
|
[NCBI]
|
9.77062e-05
|
|
|
GAN1
|
[NCBI]
|
9.10648e-05
|
|
|
NDUFS8
|
[NCBI]
|
9.01353e-05
|
|
|
MTND6
|
[NCBI]
|
8.98919e-05
|
|
|
MTND5
|
[NCBI]
|
8.85154e-05
|
|
|
HPS
|
[NCBI]
|
8.67229e-05
|
|
|
NOX1
|
[NCBI]
|
7.96183e-05
|
|
|
mitochondrial dna depletion syndrome, myopathic form
|
[NCBI]
|
7.77817e-05
|
|
|
NDUFB3
|
[NCBI]
|
7.71186e-05
|
|
|
ENOX1
|
[NCBI]
|
7.71186e-05
|
|
|
NDUFAF1
|
[NCBI]
|
7.71186e-05
|
|
|
NDUFA5
|
[NCBI]
|
7.71186e-05
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
7.1948e-05
|
|
|
TRMA
|
[NCBI]
|
7.07018e-05
|
|
|
XDH
|
[NCBI]
|
6.92534e-05
|
|
|
NDUFA8
|
[NCBI]
|
6.22795e-05
|
|
|
CYBB
|
[NCBI]
|
6.15051e-05
|
|
|
MEOX1
|
[NCBI]
|
5.91108e-05
|
|
|
NDUFB6
|
[NCBI]
|
5.91108e-05
|
|
|
NOX4
|
[NCBI]
|
5.66835e-05
|
|
|
NDUFS1
|
[NCBI]
|
5.66835e-05
|
|
|
NOXO1
|
[NCBI]
|
5.47126e-05
|
|
|
CDSP
|
[NCBI]
|
4.80464e-05
|
|
|
CF
|
[NCBI]
|
4.72609e-05
|
|
|
MTND4L
|
[NCBI]
|
4.4893e-05
|
|
|
PDCD8
|
[NCBI]
|
4.32369e-05
|
|
|
MPO
|
[NCBI]
|
3.91331e-05
|
|
|
cytochrome b5 reductase 2
|
[NCBI]
|
3.8546e-05
|
|
|
PECR
|
[NCBI]
|
3.8546e-05
|
|
|
MECR
|
[NCBI]
|
3.8546e-05
|
|
|
NQO3A2
|
[NCBI]
|
3.8546e-05
|
|
|
NDUFA4
|
[NCBI]
|
3.8546e-05
|
|
|
NDUFB5
|
[NCBI]
|
3.8546e-05
|
|
|
ZS
|
[NCBI]
|
3.44465e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.36125e-05
|
|
|
MTCYB
|
[NCBI]
|
3.3476e-05
|
|
|
NOXA1
|
[NCBI]
|
3.11265e-05
|
|
|
NCB5OR
|
[NCBI]
|
3.11265e-05
|
|
|
NDUFV3
|
[NCBI]
|
3.11265e-05
|
|
|
KSS
|
[NCBI]
|
3.07799e-05
|
|
|
MB
|
[NCBI]
|
3.00466e-05
|
|
|
MTND4
|
[NCBI]
|
2.97068e-05
|
|
|
BLVRB
|
[NCBI]
|
2.83285e-05
|
|
|
NDUFA6
|
[NCBI]
|
2.83285e-05
|
|
|
NDOR1
|
[NCBI]
|
2.83285e-05
|
|
|
NDUFC1
|
[NCBI]
|
2.65129e-05
|
|
|
NDUFS6
|
[NCBI]
|
2.65129e-05
|
|
|
NDUFS5
|
[NCBI]
|
2.65129e-05
|
|
|
NDUFS7
|
[NCBI]
|
2.65129e-05
|
|
|
NDUFB7
|
[NCBI]
|
2.65129e-05
|
|
|
NDUFB9
|
[NCBI]
|
2.65129e-05
|
|
|
MTTG
|
[NCBI]
|
2.65129e-05
|
|
|
NDUFS3
|
[NCBI]
|
2.51639e-05
|
|
|
NDUFA2
|
[NCBI]
|
2.51639e-05
|
|
|
FDXR
|
[NCBI]
|
2.40896e-05
|
|
|
PCK2
|
[NCBI]
|
2.31969e-05
|
|
|
MTTE
|
[NCBI]
|
2.24333e-05
|
|
|
PAK1
|
[NCBI]
|
2.24333e-05
|
|
|
TK2
|
[NCBI]
|
2.17662e-05
|
|
|
EYA2
|
[NCBI]
|
2.17662e-05
|
|
|
SLC19A2
|
[NCBI]
|
2.1174e-05
|
|
|
WARS
|
[NCBI]
|
2.06416e-05
|
|
|
SIX1
|
[NCBI]
|
2.01581e-05
|
|
|
DGUOK
|
[NCBI]
|
1.97153e-05
|
|
|
NQO1
|
[NCBI]
|
1.89282e-05
|
|
|
ATP5O
|
[NCBI]
|
1.89282e-05
|
|
|
HEPH
|
[NCBI]
|
1.85749e-05
|
|
|
TXN
|
[NCBI]
|
1.8244e-05
|
|
|
PAK2
|
[NCBI]
|
1.8244e-05
|
|
|
VEGF
|
[NCBI]
|
1.70781e-05
|
|
|
MAP3K7
|
[NCBI]
|
1.66067e-05
|
|
|
MTND3
|
[NCBI]
|
1.61586e-05
|
|
|
MTND2
|
[NCBI]
|
1.57464e-05
|
|
|
DLD
|
[NCBI]
|
1.53647e-05
|
|
|
NOS1
|
[NCBI]
|
1.53647e-05
|
|
|
SLC25A4
|
[NCBI]
|
1.50095e-05
|
|
|
ADH5
|
[NCBI]
|
1.42165e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.34042e-05
|
|
|
CD47
|
[NCBI]
|
1.22881e-05
|
|
|
PAX3
|
[NCBI]
|
1.2092e-05
|
|
|
UNG
|
[NCBI]
|
1.18118e-05
|
|
|
MMP2
|
[NCBI]
|
1.07549e-05
|
|
|
MTTL1
|
[NCBI]
|
1.02034e-05
|
|
|
SNCA
|
[NCBI]
|
1.0075e-05
|
|
|
H6PD
|
[NCBI]
|
9.42497e-06
|
|
|
PPIA
|
[NCBI]
|
7.66204e-06
|
|
|
TLR4
|
[NCBI]
|
7.56949e-06
|
|
|
G6PD
|
[NCBI]
|
7.04715e-06
|
|
|
SLPI
|
[NCBI]
|
6.72581e-06
|
|
|
VASP
|
[NCBI]
|
6.57844e-06
|
|
|
EGFR
|
[NCBI]
|
6.51616e-06
|
|
|
EGF
|
[NCBI]
|
4.52166e-06
|
|
|
PD
|
[NCBI]
|
3.57723e-06
|
|
|
VIP
|
[NCBI]
|
3.4607e-06
|
|
|
LDLR
|
[NCBI]
|
3.2712e-06
|
|
|
STAT3
|
[NCBI]
|
2.91477e-06
|
|
|
TPO
|
[NCBI]
|
2.17772e-06
|
|
|
AR
|
[NCBI]
|
1.81921e-06
|
|
|
ACHE
|
[NCBI]
|
1.69113e-06
|
|
|
SOD2
|
[NCBI]
|
1.20472e-06
|
|
|
TH
|
[NCBI]
|
1.07291e-06
|
|
|
LPL
|
[NCBI]
|
1.0224e-06
|
|
|
TNF
|
[NCBI]
|
6.29701e-07
|
|
|
COMT
|
[NCBI]
|
5.94089e-07
|
|
|
NPPA
|
[NCBI]
|
5.83846e-07
|
|
|
CNTF
|
[NCBI]
|
5.17336e-07
|
|
|
EPO
|
[NCBI]
|
4.8446e-07
|
|
|
GAPDH
|
[NCBI]
|
3.56975e-07
|
|
|
TF
|
[NCBI]
|
3.02556e-07
|
|
|
HBB
|
[NCBI]
|
1.68768e-07
|
|
|
CAT
|
[NCBI]
|
1.54192e-07
|
|
|
NPY
|
[NCBI]
|
4.17247e-08
|
|
|
DHFR
|
[NCBI]
|
1.7455e-08
|
|